Financing and reimbursement models for personalised medicine: A systematic review to identify current models and future options by Koleva-Kolarova, R, Buchanan, J, Vellekoop, H, Huygens, S, Versteegh, M, Mölken, MR-V, Szilberhorn, L, Zelei, T, Nagy, B, Wordsworth, S, Tsiachristas, A, HEcoPerMed Consortium

Guidance for the harmonisation and improvement of economic evaluations of personalised medicine by Vellekoop, H, Huygens, S, Versteegh, M, Szilberhorn, L, Zelei, T, Nagy, B, Koleva-Kolarova, R, Tsiachristas, A, Wordsworth, S, Rutten-van Mölken, M

Other Authors: “…HEcoPerMed Consortium…”

Cost-effectiveness analysis of treating patients with ntrk-positive cancer with the histology-independent therapy entrectinib by Huygens, S, Vellekoop, H, Versteegh, M, Santi, I, Szilberhorn, L, Zelei, T, Nagy, B, Tsiachristas, A, Koleva-Kolarova, R, Wordsworth, S, Rutten-van Mölken, M

Other Authors: “…HEcoPerMed consortium…”